TP53 and glioblastoma: Haas-Kogan et al., observed increased radio-resistance to fractionated radiation therapy (RT) in GBM cells expressing mutated p53 [11], while transduction of wild type p53 in the 9L GBM cell line increased sensitivity to cisplatin [12].